Thoraflex™ Hybrid THP3036X150ARecalls & reported problems
Vascutek Ltd · Thoraflex Hybrid Plexus 4 Hybrid Stent Device · Class 3 · Implant
All models of Thoraflex Hybrid (33)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 05037881026848), received between Jun 18, 2024 and Aug 18, 2025 — classified as 1 death, 2 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Insufficient Device Problem Information2
- Device Endoleak1
Patient problems
- Insufficient Information2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Multiple Organ Dysfunction Syndrome1
- Obstruction/Occlusion1
- Stroke/CVA1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
DeathAug 18, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
THE PATIENT WAS ADMITTED ON (B)(6) 2024 AND DIED ON (B)(6) 2024. CAUSE OF DEATH IS CURRENTLY UNKNOWN.
Patient problems: Insufficient Information; Multiple Organ Dysfunction Syndrome; Obstruction/Occlusion
MAUDE report 22828025 ↗InjuryApr 9, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
EXTEND-001 (NCT05639400), SITE NO. (B)(4): ON POST OP DAY 1 SEDATION WAS WEANED OFF AND DID NOT WAKE UP AND WAS TAKEN FOR A HEAD CT SCAN WHICH DEMONSTRATED A RIGHT M2 OCCLUSION WITH EXTENSIVE INFARCT IN THE RIGHT MCA (MIDDLE CEREBRAL ARTERY), RIGHT PCA (POSTERIOR CEREBRAL ARTERY) AND RIGHT ACA (ANTERIOR CEREBRAL ARTERY) TERRITORIES. THE PATIENT CONDITION WORSENED ON POST OP DAY 5 AND WAS TAKEN FOR A REPEAT HCT (HEAD COMPUTED TOMOGRAPHY) SHOWING NEW MASS EFFECT OF THE RIGHT VENTRICLES AND EFFACEMENT WITH MIDLINE SHIFT FROM RIGHT TO LEFT WITH CONCERN FOR HERNIATION. NEUROSURGERY RECOMMENDED TO CONTINUE WITH MEDICAL MANAGEMENT. ON POST OPERATIVE DAY ONE (B)(6)2024), THE PATIENT HAD A SLOW EMERGENCE FROM SEDATION WEAN FOUND TO HAVE STROKES IN RIGHT MCA. HCT DEMONSTRATED "PROXIMAL RIGHT M2 MCA ANTERIOR DIVISION LARGE VESSEL OCCLUSION WITH INFARCT IN THE RIGHT MCA, PCA AND ACA TERRITORIES. MRS (MODIFIED RANKIN SCORE) ON (B)(6) 2024 WAS DOCUMENTED AS 0 (NO SYMPTOMS AT ALL). MRS ON (B)(6) 2024 (32 DAYS POST PROCEDURE) WAS 5 (SEVERE DISABILITY, BEDRIDDEN, INCONTINENT, REQUIRING CONSTANT NURSING CARE AND ATTENTION). SPINAL CORD ISCHAEMIA GUIDE ON (B)(6)2024 (32 DAYS POST PROCEDURE) WAS 3B (N
Patient problems: Stroke/CVA
MAUDE report 21805167 ↗InjuryJun 18, 2024Device Endoleak; Device Endoleak
AS REPORTED BY THE EXTEND-001 STUDY: IMPLANT DATE WAS (B)(6)2024, EVENT DATE WAS 16 MAY 24. EVENT REPORTED AS ENDOLEAK THROUGH THE EXISTING THORACIC ENDOVASCULAR AORTIC DEVICES. THORACIC ENDOVASCULAR AORTIC ANEURYSM REPAIR NOT INVOLVING LT SUBCLAVIAN ARTERY RELINES THE EXISTING DEVICES AND EXTEND TO TREAT THE POOR TRUE LUMEN EXPANSION IN THE DISTAL DESCENDING THORACIC AORTA. SURGICAL INTERVENTION WAS MARKED AS REQUIRED, BUT NO CONFIRMATION OF WHAT INTERVENTION WAS PERFORMED. PATIENT PRE-EXISTING CONDITIONS: HYPERTENSION, TYPE 2 DIABETES, ERECTILE DYSFUNCTION, AND PREVIOUS EMERGENT TYPE A DISSECTION REPAIR ASCENDING AORTA REPLACEMENT. THIS EVENT OCCURRED AFTER PROCEDURE AND THE PERIOD OF THE EVENT OCCURRED FOR 36 DAYS. THIS EVENT HAS BEEN MARKED AS DEVICE RELATED (WITHOUT DEVICE DEFICIENCY DESCRIPTION), POSSIBLY PROCEDURE RELATED AND NO INFORMATION IF IS RELATED TO PATIENT PREEXISTING CONDITION. PATIENT RECOVERED AND RESOLVED WITH TREATMENT ON (B)(6) 2024.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Insufficient Information
MAUDE report 19556172 ↗
Other Hybrid stent graft, thoracic aortic lesion treatment devices
- Thoraflex™ Hybrid THP3032X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment3 deaths8 reports
- Thoraflex™ Hybrid THP3036X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment7 reports
- Thoraflex™ Hybrid THP3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THA3036X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THP2830X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THA3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment2 deaths3 reports
- Thoraflex™ Hybrid THA2830X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment1 death3 reports
- Thoraflex™ Hybrid THA3034X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page